Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA.
Sakamoto N, Tanabe Y, Yokota T, Satoh K, Sekine-Osajima Y, Nakagawa M, Itsui Y, Tasaka M, Sakurai Y, Cheng-Hsin C, Yano M, Ohkoshi S, Aoyagi Y, Maekawa S, Enomoto N, Kohara M, Watanabe M. Sakamoto N, et al. J Gastroenterol Hepatol. 2008 Sep;23(9):1437-47. doi: 10.1111/j.1440-1746.2007.05076.x. Epub 2007 Aug 7. J Gastroenterol Hepatol. 2008. PMID: 17683479 Free PMC article.
Development of plaque assays for hepatitis C virus-JFH1 strain and isolation of mutants with enhanced cytopathogenicity and replication capacity.
Sekine-Osajima Y, Sakamoto N, Mishima K, Nakagawa M, Itsui Y, Tasaka M, Nishimura-Sakurai Y, Chen CH, Kanai T, Tsuchiya K, Wakita T, Enomoto N, Watanabe M. Sekine-Osajima Y, et al. Virology. 2008 Feb 5;371(1):71-85. doi: 10.1016/j.virol.2007.09.019. Epub 2007 Oct 22. Virology. 2008. PMID: 17949770 Free article.
Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein.
Itsui Y, Sakamoto N, Kakinuma S, Nakagawa M, Sekine-Osajima Y, Tasaka-Fujita M, Nishimura-Sakurai Y, Suda G, Karakama Y, Mishima K, Yamamoto M, Watanabe T, Ueyama M, Funaoka Y, Azuma S, Watanabe M. Itsui Y, et al. Among authors: sekine osajima y. Hepatology. 2009 Dec;50(6):1727-37. doi: 10.1002/hep.23195. Hepatology. 2009. PMID: 19821486
Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells.
Nishimura-Sakurai Y, Sakamoto N, Mogushi K, Nagaie S, Nakagawa M, Itsui Y, Tasaka-Fujita M, Onuki-Karakama Y, Suda G, Mishima K, Yamamoto M, Ueyama M, Funaoka Y, Watanabe T, Azuma S, Sekine-Osajima Y, Kakinuma S, Tsuchiya K, Enomoto N, Tanaka H, Watanabe M. Nishimura-Sakurai Y, et al. Among authors: sekine osajima y. J Gastroenterol. 2010 May;45(5):523-36. doi: 10.1007/s00535-009-0162-3. Epub 2009 Dec 12. J Gastroenterol. 2010. PMID: 20012654
Cell culture and in vivo analyses of cytopathic hepatitis C virus mutants.
Mishima K, Sakamoto N, Sekine-Osajima Y, Nakagawa M, Itsui Y, Azuma S, Kakinuma S, Kiyohashi K, Kitazume A, Tsuchiya K, Imamura M, Hiraga N, Chayama K, Wakita T, Watanabe M. Mishima K, et al. Among authors: sekine osajima y. Virology. 2010 Sep 30;405(2):361-9. doi: 10.1016/j.virol.2010.06.020. Epub 2010 Jul 6. Virology. 2010. PMID: 20609455 Free article.
Serum interleukin-6 levels correlate with resistance to treatment of chronic hepatitis C infection with pegylated-interferon-α2b plus ribavirin.
Ueyama M, Nakagawa M, Sakamoto N, Onozuka I, Funaoka Y, Watanabe T, Nitta S, Kiyohashi K, Kitazume A, Murakawa M, Nishimura-Sakurai Y, Sekine-Osajima Y, Itsui Y, Azuma S, Kakinuma S, Watanabe M; Ochanomizu-Liver Conference Study Group. Ueyama M, et al. Among authors: sekine osajima y. Antivir Ther. 2011;16(7):1081-91. doi: 10.3851/IMP1864. Antivir Ther. 2011. PMID: 22024524
12 results